-
Alosetron A3157 for Reliable Cell Assays
2026-09-17
Learn how Alosetron (SKU A3157) can serve as a controlled 5-HT3 receptor pharmacology tool in intestinal proliferation, viability, and cytotoxicity workflows. This scenario-based guide connects product specifications with practical assay controls and the CDC42–YAP–mTOR literature while clearly separating established evidence from research hypotheses.
-
7-dehydro Cholesterol: Applied Research Workflows
2026-09-17
Use 7-dehydro Cholesterol to interrogate DHCR7-dependent sterol flux, UVB-driven vitamin D3 formation, and oxidation-sensitive signaling with controlled, assay-ready workflows. The guide also translates a dhcr7-edited grass carp study into practical controls for lipid, immune, and tissue-response experiments.
-
Disulfiram for Reproducible Cell Viability Assays
2026-09-16
This scenario-based guide explains how Disulfiram, SKU A4015, can support reproducible viability, proliferation, apoptosis, and proteasome studies. It combines practical formulation guidance with evidence from APC-deficient colorectal cancer and established cancer research models.
-
KPT-330 (Selinexor): From Mechanism to Assay Design
2026-09-15
KPT-330 (Selinexor) is a selective CRM1 inhibitor that converts nuclear export biology into a practical framework for cancer research. This guide emphasizes evidence-based assay design, combination testing, and translational interpretation in triple-negative breast cancer models.
-
Capsaicin: TRPV1 and KDM1A Research Guide
2026-09-15
Capsaicin, also called (E)-Capsaicin, is a TRPV1 ion channel activator and a reversible KDM1A/LSD1 inhibitor. Its research utility spans pain signaling pathway studies, inflammation signaling, chronic dermatitis, gastric cancer, and neuronal models, but assay concentration and biological context determine interpretation.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-14
Wang et al. identify a METTL16–SENP3–LTF signaling axis that protects hepatocellular carcinoma cells from ferroptosis by limiting labile iron. The study connects m6A-dependent RNA regulation with de-SUMOylation, LTF stability, tumor progression, and poor clinical prognosis, providing a mechanistic framework for ferroptosis-sensitizing strategies.
-
Naftifine HCl: Assay Boundaries and Biology
2026-09-14
Naftifine HCl is an allylamine antifungal agent for dissecting sterol-dependent membrane biology. This article connects its mechanism with lessons from WNT5a/GSK3/β-catenin research while defining assay boundaries and practical interpretation standards.
-
PINK1 Deficiency in Bleomycin-Induced Fibrosis
2026-09-13
The reference study identifies PINK1 as more than a driver of canonical mitophagy: in bleomycin-induced lung injury, it suppresses BNIP3- and FUNDC1-mediated mitochondrial clearance. Genetic PINK1 deficiency enhanced this alternative quality-control route, reduced epithelial apoptosis, and attenuated pulmonary fibrosis in mice, providing a mechanistic framework for future pulmonary fibrosis research.
-
Ibuprofen as an Emerging Environmental Contaminant
2026-09-12
Jan-Roblero and Cruz-Maya review how widespread ibuprofen use, environmental persistence, and biological toxicity converge to create an emerging-contaminant problem. The paper’s main practical contribution is to connect evidence on aquatic and soil effects with bacterial biodegradation as a potential, but not yet fully validated, remediation strategy.
-
Dinaciclib Selectively Targets VHL-Deficient ccRCC
2026-09-12
The 2022 Cell Cycle study identified a synthetic-lethal relationship between the CDK inhibitor Dinaciclib and loss of the VHL tumor suppressor in clear cell renal cell carcinoma. Its integrated cell-based, molecular, and orthotopic xenograft experiments support selective activity against proliferating VHL-deficient tumor cells, including CD105-positive and CD105-negative populations, while defining important limits for translation.
-
NMDA–Connexin Signaling in TMJ Inflammatory Allodynia
2026-09-11
This study identifies distinct roles for GluN2A and GluN2B N-methyl-D-aspartate receptor subunits in regulating connexin- and pannexin-associated signaling within the trigeminal ganglion during temporomandibular joint inflammation. Through conditional genetics, behavioral testing, satellite glial cell experiments, and pathway analysis, it links NMDAR activity to peripheral sensitization and suggests several mechanistic targets for orofacial pain research.
-
BCL6–ESM1 Suppression of CD4+ T Cells in HCC
2026-09-11
The reference study identifies cancer-cell BCL6 as an immune-evasion regulator in hepatocellular carcinoma, with a particularly important effect on tumor-infiltrating CD4+ T cells. Its proposed BCL6–ESM1 axis connects altered cytokine and chemokine signaling with reduced lymphocyte recruitment and activation, suggesting a mechanistic route for improving immune-based HCC treatment strategies.
-
Ceftolozane Sulfate: Applied PK/PD Workflows
2026-09-10
Build a connected research workflow around Ceftolozane sulfate, from MIC determination and time-kill testing to resistance profiling and translational PK/PD modeling. The approach distinguishes AmpC-stable activity from carbapenemase-associated failure while improving assay reproducibility.
-
LY2886721: Smarter BACE1 Assay Design
2026-09-10
Explore LY2886721, a potent BACE inhibitor, through an assay framework that connects amyloid beta reduction with APP-fragment balance and synaptic function. Learn how to interpret partial BACE1 enzyme inhibition without mistaking biochemical potency for physiological safety.
-
2-Hydroxypropyl-β-cyclodextrin Protocol Guide
2026-09-09
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide solubilizer for screening poorly water-soluble compounds, particularly molecules with aromatic or phenyl groups. It is appropriate for pharmaceutical and biochemical solubility workflows, but product data alone do not establish therapeutic efficacy, in vivo bioavailability, or suitability for unrelated applications.